The Brigham Board Review in Oncology 2017 – Videos + PDF

The Brigham Board Review in Oncology 2017 – Videos + PDF

Brigham and Women’s Hospital and Oakstone Board Review

Prepare for your medical oncology board exam with this in-depth CME program. Ideal for MOC.

Earn CME Credit with this Comprehensive Board Review in Oncology

The Brigham Board Review in Oncology is a CME course designed to update knowledge and improve management strategies. Case-based presentations from a distinguished faculty of experts will enhance patient care while you prep for the board exam by learning to:

• Apply recommended Oncology guidelines in clinical practice
• Perform differential diagnosis of complex Oncologic disorders
• Identify and apply current therapeutic options for Oncologic disorders
• Evaluate and interpret up-to-date literature relevant to Oncology

Discover New Guidelines

A clinically based update, this learn-at-your-own-pace course in Oncology provides a maximum of 31.25 AMA PRA Category 1 Credits ™ and 31.25 MOC points. Available online or on disk, it provides access to unbiased, evidence-based content and case-based reviews so that you may expand your knowledge and incorporate the latest guidelines into your daily practice.

View our full list of Topics/Speakers, Faculty, Accreditation and Media Format information.

• Molecular Genetics of Cancer – Levi A. Garraway, MD, PhD

• Advances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD

• Infections in Cancer Patients – Joel T. Katz, MD

• Symptom Management in Patients with Cancer – Janet L. Abrahm, MD

• Communication: The Key to Excellence in End-of-Life Care – Susan D. Block, MD

• Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD

• Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD

• Acute Leukemias – Daniel J. DeAngelo, MD, PhD

• Myelodysplastic Syndrome – David P. Steensma, MD

• Chronic Myelogenous Leukemia – Joseph H. Antin. MD

• Myeloproliferative Syndromes – Ann M. Mullally, MD

• Multiple Myeloma – Kenneth C. Anderson, MD

• Waldenstrom’s Macroglobulemia, Amyloidosis – Irene M. Ghobrial, MD

• Low Grade Lymphomas – Caron A. Jacobson, MD

• High Grade Lymphomas – Arnold S. Freedman, MD

• Hodgkin’s Lymphoma – George P. Canellos, MD

• Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD

• Head and Neck Cancer – Robert I. Haddad, MD

• Natural History, Screening, Surgery, Small Cell Lung Cancer – Bruce E. Johnson, MD

• Non Small Cell Lung Cancer – Mark Awad, MD

• Mesothelioma and Thymoma – Geoffrey R. Oxnard, MD

• Thyroid Cancer – Jochen Lorch, MD

• Carcinoid and Pancreatic Neuroendocrine Tumors – Matthew H. Kulke, MD

• Esophageal and Gastric Cancer – Charles S. Fuchs, MD, MPH

• Pancreatic and Hepatobilary Cancer – Brian M. Wolpin, MD

• Anal Cancers – Robert J. Mayer, MD

• Colorectal Cancers – Robert J. Mayer, MD

• Gastrointestinal Cancer- Genetic Syndromes – Matthew Yurgelun, MD

• Germ Cell Tumor – Maximizing Cure While Minimizing the Burden of Therapy – Christopher J. Sweeney, MBBS

• Renal and Bladder Cancer – Toni K. Choueiri, MD

• Prostate Cancer Part I: Overview and Management of Localized Disease – Atish Choudhury, MD, PhD

• Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish Choudhury, MD, PhD

• Melanoma – F. Stephen Hodi, MD

• Sarcomas and Gastrointestinal Stromal Tumors (GIST) – George D. Demetri, MD

• Ovarian Cancer – Ursula A. Matulonis, MD

• Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD

• Neuro-oncology – David A. Reardon, MD

• Breast Cancer: Risk Factors, Genetics, Screening and Prevention – Judy E. Garber, MD, MPH

• Breast Cancer: Advances in Staging, Prognosis, Surgery and Radiation, and DCIS – Harold J. Burstein, MD, PhD

• Management for HER2-Positive and Triple Negative Breast Cancer – Eric P. Winer, MD

• Breast Cancer Survivorship – Ann H. Partridge, MD, MPH